RE: Affimers v Aptamers23 Jan 2021 18:19
No debate,I think Steve’s last sentence says it all.
Steve Burton, President of Astrea Bioseparations commented:
"Affimer reagents are high-performance proteinaceous ligands that have been engineered for a wide range of applications as superior alternatives to antibody-based ligands. They can be used to selectively bind difficult targets, even where antibodies and aptamers have shown limitations.